Toxicity of amphetamines: an update
Top Cited Papers
- 6 March 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Archives of Toxicology
- Vol. 86 (8), 1167-1231
- https://doi.org/10.1007/s00204-012-0815-5
Abstract
Amphetamines represent a class of psychotropic compounds, widely abused for their stimulant, euphoric, anorectic, and, in some cases, emphathogenic, entactogenic, and hallucinogenic properties. These compounds derive from the β-phenylethylamine core structure and are kinetically and dynamically characterized by easily crossing the blood-brain barrier, to resist brain biotransformation and to release monoamine neurotransmitters from nerve endings. Although amphetamines are widely acknowledged as synthetic drugs, of which amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are well-known examples, humans have used natural amphetamines for several millenniums, through the consumption of amphetamines produced in plants, namely cathinone (khat), obtained from the plant Catha edulis and ephedrine, obtained from various plants in the genus Ephedra. More recently, a wave of new amphetamines has emerged in the market, mainly constituted of cathinone derivatives, including mephedrone, methylone, methedrone, and buthylone, among others. Although intoxications by amphetamines continue to be common causes of emergency department and hospital admissions, it is frequent to find the sophism that amphetamine derivatives, namely those appearing more recently, are relatively safe. However, human intoxications by these drugs are increasingly being reported, with similar patterns compared to those previously seen with classical amphetamines. That is not surprising, considering the similar structures and mechanisms of action among the different amphetamines, conferring similar toxicokinetic and toxicological profiles to these compounds. The aim of the present review is to give an insight into the pharmacokinetics, general mechanisms of biological and toxicological actions, and the main target organs for the toxicity of amphetamines. Although there is still scarce knowledge from novel amphetamines to draw mechanistic insights, the long-studied classical amphetamines-amphetamine itself, as well as methamphetamine and MDMA, provide plenty of data that may be useful to predict toxicological outcome to improvident abusers and are for that reason the main focus of this review.Keywords
This publication has 525 references indexed in Scilit:
- Adderall induced inverted‐Takotsubo cardiomyopathyCatheterization and Cardiovascular Interventions, 2011
- Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol)Psychopharmacology, 2010
- Metabolites of MDMA Induce Oxidative Stress and Contractile Dysfunction in Adult Rat Left Ventricular MyocytesCardiovascular Toxicology, 2009
- A Comparison of Echocardiographic Findings in Young Adults With Cardiomyopathy: With and Without a History of Methamphetamine AbuseClinical Cardiology, 2009
- Mechanism of 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy)‐mediated mitochondrial dysfunction in rat liverProteomics, 2008
- Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performancePsychopharmacology, 2008
- Effects of ambient temperature on the relative reinforcing strength of MDMA using a choice procedure in monkeysPsychopharmacology, 2007
- The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controlsPsychopharmacology, 2006
- An association study of the brain‐derived neurotrophic factor Val66Met polymorphism and amphetamine responseNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2006
- Fatal poisoning by MDMA (ecstasy) and MDEA: A case reportInternational journal of legal medicine, 1996